SARC Business Meeting

November 2005

Trial Update

• SARC 001 Gleevec– Closed to accrual– Outstanding data– Requests

• SARC 002 STS/gem-txt– Closed to accrual– Outstanding data– Requests

Trial UpdateSARC 003 bone/gem-txt

• IRB/Contracts– Mayo– MDAnderson 5– NCI 3– Ortho Hosp– Penn– Univ of MI 2– Wash Cancer 1– Yale 1

• Contracts– Partners– Emory– Univ Florida

• Neither– MSKCC– Seattle– UCLA– Univ Toronto– Moffitt

Trial UpdateSARC 004

• DFSP/Gleevec– University of Michigan– Seattle– Partners– MSKCC– MDAnderson

Trial Update

• SARC 005– Adjuvant uterine/

gem/txt– IRB approval

pending from MSKCC

– Contracts– Database

development– GOG

• SARC 006– MPNST– DoD– Database

development

• Data capture– Web based– Ongoing training for

data quality– CACR

Center for the Advancement of Clinical Research

• Michigan

• Drug distribution– Centralized pharmacy– Reputation for quality– Biologics

• North Carolina

Trial Support

Location

• Rented office space– Dominos Farms

24 Frank Lloyd Wright Dr

Ann Arbor, MI

Employees

• Administrative assistant– Barb Thibert

• Accountant– Keith Locke

• Research Project Manager– Emily Hollenberg, RN, MPH

Finances

• Income (from inception 11/03)– $505,156

• Expenses (from inception 11/03)– $192,202

Finances• Income (by category)

– Biannual meeting $ 15,000– Donations $ 20,000– Guideline Translation $ 25,000– Primary Vascular $ 4,300– Rosenfeld Symposia $ 50,000– SARC 002 $ 92,356– SARC 003 $ 40,000 ($ 78,000)– SARC 004 $ 25,000– Scientific Symposia $133,500– Website Development $100,000

$505,156

Finances

• Expenses (by category)– Biannual meeting $ 17,871– Operating expenses $ 49,650– SARC 002 $ 52,332– SARC 003 $ 40,229– Scientific symposia $ 31,942– Website development $ 180

$192,202

Executive Committee

• Monthly calls

• Review all trials

• Discuss protocols in development

Board of Directors

• Annual Meeting– November 18,2005

Development Subcommittee

• Members– Deborah Buks– David Marsh– Tim McCormick– Charles Nearberg

• Activities– Discuss strategies – Evaluate potential opportunities

Eugene and MaxineRosenfeld

David Marsh

The Silver Fox Club contributes 10 percent of its sales to helping those with sarcoma cancer, which has affected the founder’s wife. Out Fox Sarcoma

Paul Corliss

Ann Foote-Primary Vascular Sarcoma Fund

Development

• Meeting with Dr. Doroshow

• Utilize website

• RO1 application

• Continue to explore additional funding opportunities

Website Development

• Proposal from

Altum/CommonHealth

Website

• Destination for sarcoma clinical trials

• Source of information – Physicians– Patients and families

• Emphasize credibility

• Call to action– Clinical trials– Support

• Link with other sites

Guideline Translation

• Nancy Leahy• Laura Zyczynski• Jenni Heaton• Joan Giblin• Kelly Scheu• Linda Sohn• Monica Davey• Lauren Long• Donna Bernstein• Terri Armen• Carolyn Hayes• Denise Parker• 7 pending

• New Business

• Future directions– Developmental therapeutics– Launch website

• Maximize – Clinical trial awareness– Education– Outreach

– Partnering